Author

Hari Bhathal

Observed name: H. Bhathal

Institution: Hospital Quirón Teknon

Observed institutions: Hospital Quirón Teknon, Hospital Universitario Infanta Leonor

OpenAlex ID: A5082701431

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex

2020 · Elizabeth A. Thiele, E. Martina Bebin, et al. · JAMA Neurology · 280

Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

2021 · Michael Privitera, Hari Bhathal, et al. · Epilepsia · 60

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials

2020 · Boudewijn Gunning, Maria Mazurkiewicz‐Bełdzińska, et al. · Acta Neurologica Scandinavica · 52

Cannabidiol (CBD) Treatment Effect and Adverse Events (AEs) by Time in Patients with Lennox-Gastaut Syndrome (LGS): Pooled Results from 2 Trials (S19.006)

2018 · Elaine C. Wirrell, Michael Privitera, et al. · Neurology · 2

IP 112. Cannabidiol Treatment Effect and Adverse Events in Patients with Lennox–Gastaut’s syndrome: Pooled Results from Two Trials

2018 · Antonio Gil-Nagel, Michael Privitera, et al. · Neuropediatrics

Adjunctive Lacosamide in Clinical Practice: A Multicenter Prospective Study in Spain, by the Central Spain Lacosamide Study Group (P06.113)

2012 · J. Parra-Gomez, J. Carod-Artal, et al. · Neurology

Works count: 7

Citation count: 674

H-index: 4

I10-index: 4